Metastatic Prostate Cancer - Market Insight, Epidemiology
Dublin, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Page 2 - Abiraterone News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Abiraterone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Abiraterone Today - Breaking & Trending Today
The Role of Combination Therapy in mCRPC
Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.
Source: curetoday.com
Life-extending prostate cancer drug postcode lottery
There is a call for more men in England and Northern Ireland to have access to the treatment.
Source: yahoo.com
Ongoing Clinical Trials in the Metastatic CRPC Setting
Key opinion leaders in metastatic castration-resistant prostate cancer share insight to key ongoing clinical trials within the landscape.
Source: onclive.com
AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer
Cambridge: AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of adult patients with BRCA-mutated (BRCAm)...
Source: medicaldialogues.in